Skip to main content

Japan’s Takeda clinches $62 billion Shire deal as pharma M&A rolls on – Reuters

By May 14, 2018News
takeda-pharma-logo

takeda-pharma-logo

Takeda Pharmaceutical agreed to buy London-listed Shire for 45.3 billion pounds ($62 billion) on Tuesday, the biggest yet in a wave of deals sweeping the drugs industry.

{iframe}https://www.reuters.com/article/us-shire-m-a-takeda/japans-takeda-agrees-62-billion-takeover-of-shire-idUSKBN1I90IC{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.